MEMPHIS, Tenn.--()--Christie Medical Holdings, Inc., formerly Luminetx® Corporation, has announced the launch of VeinViewer® Vision, the third generation of VeinViewer technology. Like its predecessor, Vision uses near-infrared light and other patented technologies to project a digital image of patient vasculature directly onto the surface of the skin in real time. This provides clinicians with a non-invasive adjunct technology for various clinical treatments and procedures including IV insertions, PICC line insertions and routine venipuncture.
“Our third generation VeinViewer is a testament to carefully listening to the demands of our global customer base”
“Our third generation VeinViewer is a testament to carefully listening to the demands of our global customer base,” said George Pinho, President of Christie Medical Holdings. “We have enhanced everything that makes us the market leader and met every customer request head-on. Vision will continue the VeinViewer tradition of helping clinicians improve venipuncture procedures and patient comfort, while the facilities in which they work receive the benefit of reduced costs, time and unnecessary procedures.”
VeinViewer Vision, now able to fit in the palm of your hand, is anchored on a smaller and more mobile cart base, allowing for an optimal hands-free technique. Vision includes advanced VeinViewer technology that provides an improved depth of focus, a long-run battery for cordless use, and an exclusive ASSESS™ imaging suite with four distinct modes, including enhanced universal and fine detail modes and new inverse and resize modes to accommodate all patient needs.
VeinViewer, originally launched in 2006, is currently sold by Christie Medical Holdings through distribution partnerships in more than 40 countries.
About Christie Medical Holdings, Inc.
Christie Medical Holdings, Inc., formerly Luminetx® Corporation, is a global company based in Memphis, Tenn. that discovers, develops and commercializes medical technologies. The company’s market leading product, VeinViewer®, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature in real time directly on the surface of the skin. Christie Medical Holdings is owned by Christie Digital Systems, Inc. a global visual technologies company and a subsidiary of Ushio, Inc., Japan (JP:6925). For more information on Christie or Christie Medical Holdings, visit www.christiedigital.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6276607&lang=en